“Formulation and optimization of liquisolid tablet for improving the dissolution profile of rivaroxaban by using DoE approachand antithrombic activity”, JOC, vol. 23, no. 1, pp. 701–719, Oct. 2025, doi: 10.64149/J.Carcinog.24.3s.812-830.